NPI registry status
Active
2026 NPPES data Internal Medicine Physician NPI 1780829374 M.D.
Verify on CMS → Mangesh Pagadala, M.D.
Internal Medicine Physician in Dallas, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
944
Medicare Part D claims · 135 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$25.8K
68 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mangesh Pagadala, M.D. filed 944 Medicare Part D claims in 2023 as an Internal Medicine Physician in Dallas, Texas, prescribing 81% generic.
- 944
- Part D claims, 2023
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥75th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1780829374 · Internal Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · RX-LIGHT · BOOK-MID · PHOTO-ENUM
- NPI-10 1780829374
- ENUM-MID 2008
- TAX-MEGA 173K Internal Medicine
- RX-LIGHT 944
- BOOK-MID 10,926 in Texas
- PHOTO-ENUM Ian Rivera · 2008
Mangesh Pagadala, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
944 ≥ 75th percentile 75% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Mangesh Pagadala, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mangesh Pagadala, M.D.?
Quality data not reportedPrimary specialty
Internal Medicine Physician
Medicare Part D claims
944 65% vs specialty avg
Specialty distribution in Texas
How Internal Medicine Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Internal Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1780829374 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/10/2008 |
Hospital and facility affiliations
Facilities where Mangesh Pagadala, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Medhealth
Dallas, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mangesh Pagadala, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$25.8K
Largest payer
Madrigal Pharmaceuticals
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Mangesh Pagadala, M.D.. To verify Mangesh Pagadala, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Mangesh Pagadala, M.D. - brand share 19.0%
Internal Medicine Physician average
19% brand-name claims vs 81% generic, on 944 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
944
Total Claims
$664K
Total Drug Cost
135
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,189
- Total Day Supply
- 34,195
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $624K
- Generic Drug Cost
- $39K
- Antibiotic Claims
- 68
Patient Demographics
- Average Patient Age
- 67.8 years
- Avg HCC Risk Score
- 3.32
- Gender Split
- 46% female / 54% male
- Age Distribution
- <65: 35, 65-74: 79, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mangesh Pagadala, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ursodiol
Ursodiol
150 claims
- Spironolactone
Spironolactone
125 claims
- Furosemide
Furosemide
113 claims
- Mycophenolate Mofe…
Mycophenolate Mofetil
65 claims
- Pantoprazole Sodium 48
Pantoprazole Sodium
48 claims
- Tacrolimus 48
Tacrolimus
48 claims
- Prednisone 45
Prednisone
45 claims
- Xifaxan 39
Xifaxan
39 claims
| Drug | Claims |
|---|---|
| Ursodiol | 150 |
| Spironolactone | 125 |
| Furosemide | 113 |
| Mycophenolate Mofetil | 65 |
| Pantoprazole Sodium | 48 |
| Tacrolimus | 48 |
| Prednisone | 45 |
| Xifaxan Rifaximin | 39 |
| Vemlidy Tenofovir Alafenamide | 36 |
| Constulose Lactulose | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Mangesh Pagadala, M.D. fits within the Internal Medicine Physician landscape nationally.
172,737
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider
Mangesh Pagadala, M.D.'s 944 claims are below the specialty average of 2,716.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Pagadala, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Pagadala.
One of 10,926 Internal Medicine Physician providers enrolled in Texas, 5 are shown here.
Dr. Muhammad A. Sattar
MD
Dallas, TX
Anunaya Aashish
Denton, TX
Dr. Queenie Ann Abad
M.D.
San Antonio, TX
Dr. Fuad Abaleka
M.D
Lubbock, TX
Dr. Carol Abalihi
M.D.
El Paso, TX
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mangesh Pagadala, M.D.'s specialty? ▼
Mangesh Pagadala, M.D. specializes in Internal Medicine Physician and practices in Dallas, Texas. Credentials: M.D..
How much does Mangesh Pagadala, M.D. prescribe under Medicare Part D? ▼
In 2023, Mangesh Pagadala, M.D. wrote 944 Medicare Part D claims totaling $664K in drug costs for 135 beneficiaries.
Where is Mangesh Pagadala, M.D. located? ▼
Mangesh Pagadala, M.D. is located at 1411 N BECKLEY AVE, Dallas, TX, 75203. Phone: (214) 947-4400.
What is Mangesh Pagadala, M.D.'s NPI number? ▼
Mangesh Pagadala, M.D.'s National Provider Identifier (NPI) is 1780829374, issued on 12/10/2008.
Does Mangesh Pagadala, M.D. prescribe more brand-name or generic drugs? ▼
Mangesh Pagadala, M.D.'s prescribing is 19% brand-name and 81% generic drugs by claim count, with $624K in brand drug costs.
How many Internal Medicine Physician providers are there in the US? ▼
There are 172,737 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does Mangesh Pagadala, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Mangesh Pagadala, M.D.'s most frequently prescribed drugs include Ursodiol, Spironolactone, Furosemide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mangesh Pagadala, M.D. accept Medicare? ▼
Mangesh Pagadala, M.D. appears in CMS Medicare data with 944 Part D claims and 135 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mangesh Pagadala, M.D.'s credentials? ▼
Mangesh Pagadala, M.D.'s NPI is 1780829374 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.